Category: Regulations
-
Preventive Drugs Offer No Benefit for Children’s Migraine
A clinical trial testing drugs for depression and seizures, but sometimes prescribed to prevent migraines, shows the drugs to be no better than a placebo in preventing migraines among children.
-
Skin Patch Shown to Increase Peanut Tolerance in Children
A skin patch worn by children with peanut allergies was shown in a clinical trial to increase the wearers’ tolerance for peanuts by 10 times after 1 year.
-
Engineered Mosquito Production Facility Opens
A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil.
-
Trial to Test Drug Combination for Hospital Infections
A clinical trial scheduled for early 2017 plans to assess the activity of two drugs to treat antibiotic-resistant infections often found in health care facilities.
-
ALS Soy Peptide Trial Completes Enrollment
A clinical trial testing a peptide found in soy as a potential treatment for amyotrophic lateral sclerosis or ALS completed its enrollment of 50 participants.
-
Trial Testing Retina Cell Implants for Glaucoma
A new clinical trial is testing implants to treat glaucoma made of genetically engineered retina cells that release hormones promoting optic nerve growth.
-
Trial Shows Ovarian Cancer Drug Safety, Therapy Potential
A clinical trial shows an experimental therapy addressing a common cancer-causing mutation is safe, with early indications of its efficacy against ovarian cancer.
-
Breast Cancer Drug Costs Vary Among Insured Patients
Women receiving chemotherapy for breast cancer can face widely different costs for their treatments, regardless of effectiveness, even if they have health insurance.
-
Adverse Effects Reports in Cancer Trials Seen Lacking
A review of clinical trials testing targeted treatments or immunotherapies for cancer show most of the studies got low scores on a standard scale for reporting adverse side effects.
-
Precision Medicine Trial Set for Pancreatic Cancer
A large-scale clinical trial is planned at 12 sites in the U.S. to test treatments for pancreatic cancer guided by the genomics of a patient’s own tumor.